U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Fallopian Tube Mucinous Adenocarcinoma

MedGen UID:
1791612
•Concept ID:
C5555171
•
Neoplastic Process

Definition

The reemergence of fallopian tube mucinous adenocarcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Fallopian Tube Mucinous Adenocarcinoma

Professional guidelines

PubMed

A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.
Bednar EM, Oakley HD, Sun CC, Burke CC, Munsell MF, Westin SN, Lu KH
Gynecol Oncol 2017 Aug;146(2):399-404. Epub 2017 Jun 10 doi: 10.1016/j.ygyno.2017.05.037. PMID: 28610746Free PMC Article
Treatment of chemotherapy-induced anemia in ovarian cancer patients: does the use of erythropoiesis-stimulating agents worsen survival?
Rocconi RP, Sullivan P, Long B, Blaize M, Brown J, Arbuckle J, Bevis K, Estes JM, Reed E, Finan MA
Int J Gynecol Cancer 2012 Jun;22(5):786-91. doi: 10.1097/IGC.0b013e31825104f4. PMID: 22552832
Treatment of ovarian cancer in young women.
Gershenson DM
Clin Obstet Gynecol 2012 Mar;55(1):65-74. doi: 10.1097/GRF.0b013e318248045b. PMID: 22343230

Recent clinical studies

Etiology

A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.
Bednar EM, Oakley HD, Sun CC, Burke CC, Munsell MF, Westin SN, Lu KH
Gynecol Oncol 2017 Aug;146(2):399-404. Epub 2017 Jun 10 doi: 10.1016/j.ygyno.2017.05.037. PMID: 28610746Free PMC Article
Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary.
Massad LS, Gao F, Hagemann I, Powell M
Gynecol Obstet Invest 2016;81(5):411-5. Epub 2015 Nov 20 doi: 10.1159/000441791. PMID: 26583769Free PMC Article
Expression of LATS family proteins in ovarian tumors and its significance.
Xu B, Sun D, Wang Z, Weng H, Wu D, Zhang X, Zhou Y, Hu W
Hum Pathol 2015 Jun;46(6):858-67. Epub 2015 Mar 5 doi: 10.1016/j.humpath.2015.02.012. PMID: 25841306
Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: tolerability and efficacy study--the Israeli experience.
Safra T, Berman T, Yachnin A, Bruchim I, Meirovitz M, Barak F, Atlas I, Levy T, Rosengarten OS
Int J Gynecol Cancer 2013 Mar;23(3):475-80. doi: 10.1097/IGC.0b013e3182866944. PMID: 23435437
What is the benefit of bevacizumab combined with chemotherapy in patients with recurrent ovarian, fallopian tube or primary peritoneal malignancies?
Cheng X, Moroney JW, Levenback CF, Fu S, Jaishuen A, Kavanagh JJ
J Chemother 2009 Nov;21(5):566-72. doi: 10.1179/joc.2009.21.5.566. PMID: 19933049

Diagnosis

Mucinous appendiceal adenocarcinoma invading the bladder: not always an easy diagnosis. A case report.
Eugenia L, Giovanni A, Andrea M, Maria Rosaria R, Gianni V, Mara B, Gherardo M, Daniele L, Lorenzo A, Andrea M, Paolo P
Anticancer Drugs 2023 Sep 1;34(8):967-969. Epub 2023 Jan 24 doi: 10.1097/CAD.0000000000001499. PMID: 36688906
Primary Mucinous Carcinoma of the Fallopian Tube: Case Report and Review of Literature.
Wheal A, Jenkins R, Mikami Y, Das N, Hirschowitz L
Int J Gynecol Pathol 2017 Jul;36(4):393-399. doi: 10.1097/PGP.0000000000000330. PMID: 27662036
Expression of LATS family proteins in ovarian tumors and its significance.
Xu B, Sun D, Wang Z, Weng H, Wu D, Zhang X, Zhou Y, Hu W
Hum Pathol 2015 Jun;46(6):858-67. Epub 2015 Mar 5 doi: 10.1016/j.humpath.2015.02.012. PMID: 25841306
Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: tolerability and efficacy study--the Israeli experience.
Safra T, Berman T, Yachnin A, Bruchim I, Meirovitz M, Barak F, Atlas I, Levy T, Rosengarten OS
Int J Gynecol Cancer 2013 Mar;23(3):475-80. doi: 10.1097/IGC.0b013e3182866944. PMID: 23435437
Treatment of ovarian cancer in young women.
Gershenson DM
Clin Obstet Gynecol 2012 Mar;55(1):65-74. doi: 10.1097/GRF.0b013e318248045b. PMID: 22343230

Therapy

Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial).
Komiyama S, Kato K, Inokuchi Y, Takano H, Matsumoto T, Hongo A, Asai-Sato M, Arakawa A, Kamiura S, Tabata T, Takeshima N, Sugiyama T
Int J Clin Oncol 2019 Jan;24(1):103-114. Epub 2018 Jul 20 doi: 10.1007/s10147-018-1319-y. PMID: 30030657Free PMC Article
A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.
Bednar EM, Oakley HD, Sun CC, Burke CC, Munsell MF, Westin SN, Lu KH
Gynecol Oncol 2017 Aug;146(2):399-404. Epub 2017 Jun 10 doi: 10.1016/j.ygyno.2017.05.037. PMID: 28610746Free PMC Article
Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: tolerability and efficacy study--the Israeli experience.
Safra T, Berman T, Yachnin A, Bruchim I, Meirovitz M, Barak F, Atlas I, Levy T, Rosengarten OS
Int J Gynecol Cancer 2013 Mar;23(3):475-80. doi: 10.1097/IGC.0b013e3182866944. PMID: 23435437
Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.
Ahmed N, Abubaker K, Findlay J, Quinn M
J Cell Biochem 2013 Jan;114(1):21-34. doi: 10.1002/jcb.24317. PMID: 22887554
What is the benefit of bevacizumab combined with chemotherapy in patients with recurrent ovarian, fallopian tube or primary peritoneal malignancies?
Cheng X, Moroney JW, Levenback CF, Fu S, Jaishuen A, Kavanagh JJ
J Chemother 2009 Nov;21(5):566-72. doi: 10.1179/joc.2009.21.5.566. PMID: 19933049

Prognosis

Mucinous appendiceal adenocarcinoma invading the bladder: not always an easy diagnosis. A case report.
Eugenia L, Giovanni A, Andrea M, Maria Rosaria R, Gianni V, Mara B, Gherardo M, Daniele L, Lorenzo A, Andrea M, Paolo P
Anticancer Drugs 2023 Sep 1;34(8):967-969. Epub 2023 Jan 24 doi: 10.1097/CAD.0000000000001499. PMID: 36688906
Synchronous Cervical Minimal Deviation Adenocarcinoma, Gastric Type Adenocarcinoma and Lobular Endocervical Glandular Hyperplasia Along with STIL in Peutz-Jeghers Syndrome: Eliciting Oncogenesis Pathways.
Neyaz A, Husain N, Deodhar M, Khurana R, Shukla S, Arora A
Turk Patoloji Derg 2019;35(3):247-253. doi: 10.5146/tjpath.2017.01406. PMID: 28832082
Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary.
Massad LS, Gao F, Hagemann I, Powell M
Gynecol Obstet Invest 2016;81(5):411-5. Epub 2015 Nov 20 doi: 10.1159/000441791. PMID: 26583769Free PMC Article
Expression of LATS family proteins in ovarian tumors and its significance.
Xu B, Sun D, Wang Z, Weng H, Wu D, Zhang X, Zhou Y, Hu W
Hum Pathol 2015 Jun;46(6):858-67. Epub 2015 Mar 5 doi: 10.1016/j.humpath.2015.02.012. PMID: 25841306
Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: tolerability and efficacy study--the Israeli experience.
Safra T, Berman T, Yachnin A, Bruchim I, Meirovitz M, Barak F, Atlas I, Levy T, Rosengarten OS
Int J Gynecol Cancer 2013 Mar;23(3):475-80. doi: 10.1097/IGC.0b013e3182866944. PMID: 23435437

Clinical prediction guides

Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial).
Komiyama S, Kato K, Inokuchi Y, Takano H, Matsumoto T, Hongo A, Asai-Sato M, Arakawa A, Kamiura S, Tabata T, Takeshima N, Sugiyama T
Int J Clin Oncol 2019 Jan;24(1):103-114. Epub 2018 Jul 20 doi: 10.1007/s10147-018-1319-y. PMID: 30030657Free PMC Article
Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary.
Massad LS, Gao F, Hagemann I, Powell M
Gynecol Obstet Invest 2016;81(5):411-5. Epub 2015 Nov 20 doi: 10.1159/000441791. PMID: 26583769Free PMC Article
Expression of LATS family proteins in ovarian tumors and its significance.
Xu B, Sun D, Wang Z, Weng H, Wu D, Zhang X, Zhou Y, Hu W
Hum Pathol 2015 Jun;46(6):858-67. Epub 2015 Mar 5 doi: 10.1016/j.humpath.2015.02.012. PMID: 25841306
Immunohistochemical localization of HE4 in benign, borderline, and malignant lesions of the ovary.
Georgakopoulos P, Mehmood S, Akalin A, Shroyer KR
Int J Gynecol Pathol 2012 Nov;31(6):517-23. doi: 10.1097/PGP.0b013e31824fe269. PMID: 23018214
What is the benefit of bevacizumab combined with chemotherapy in patients with recurrent ovarian, fallopian tube or primary peritoneal malignancies?
Cheng X, Moroney JW, Levenback CF, Fu S, Jaishuen A, Kavanagh JJ
J Chemother 2009 Nov;21(5):566-72. doi: 10.1179/joc.2009.21.5.566. PMID: 19933049

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...